New Risk • Jun 05
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹944.1m (US$9.87m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.6x net interest cover). High level of non-cash earnings (40% accrual ratio). Market cap is less than US$10m (₹944.1m market cap, or US$9.87m). Minor Risk Profit margins are more than 30% lower than last year (2.2% net profit margin). Reported Earnings • May 31
Full year 2026 earnings released: EPS: ₹1.10 (vs ₹4.65 in FY 2025) Full year 2026 results: EPS: ₹1.10 (down from ₹4.65 in FY 2025). Revenue: ₹805.8m (up 29% from FY 2025). Net income: ₹18.1m (down 71% from FY 2025). Profit margin: 2.2% (down from 9.8% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Mar 17
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹920.2m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.1% operating cash flow to total debt). Market cap is less than US$10m (₹920.2m market cap, or US$9.96m). Minor Risk Share price has been volatile over the past 3 months (8.8% average weekly change). Valuation Update With 7 Day Price Move • Mar 16
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₹72.42, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 15x in the Packaging industry in India. Total returns to shareholders of 194% over the past three years. Reported Earnings • Feb 13
Third quarter 2026 earnings released: EPS: ₹1.44 (vs ₹0.76 in 3Q 2025) Third quarter 2026 results: EPS: ₹1.44 (up from ₹0.76 in 3Q 2025). Revenue: ₹207.5m (up 42% from 3Q 2025). Net income: ₹18.9m (up 85% from 3Q 2025). Profit margin: 9.1% (up from 7.0% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth. Annuncio • Feb 02
Raaj Medisafe India Limited to Report Q3, 2026 Results on Feb 11, 2026 Raaj Medisafe India Limited announced that they will report Q3, 2026 results on Feb 11, 2026 Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹96.00, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 16x in the Packaging industry in India. Total returns to shareholders of 215% over the past three years. Valuation Update With 7 Day Price Move • Jan 07
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to ₹89.20, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 16x in the Packaging industry in India. Total returns to shareholders of 174% over the past three years. New Risk • Dec 04
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹894.2m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.1% operating cash flow to total debt). High level of non-cash earnings (39% accrual ratio). Market cap is less than US$10m (₹894.2m market cap, or US$9.95m). Valuation Update With 7 Day Price Move • Dec 01
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₹68.74, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 17x in the Packaging industry in India. Total returns to shareholders of 109% over the past three years. Reported Earnings • Nov 13
Second quarter 2026 earnings released: EPS: ₹1.32 (vs ₹0.49 in 2Q 2025) Second quarter 2026 results: EPS: ₹1.32 (up from ₹0.49 in 2Q 2025). Revenue: ₹186.4m (up 49% from 2Q 2025). Net income: ₹17.3m (up 165% from 2Q 2025). Profit margin: 9.3% (up from 5.2% in 2Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth. Annuncio • Nov 05
Raaj Medisafe India Limited to Report Q2, 2026 Results on Nov 12, 2025 Raaj Medisafe India Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 12, 2025 Valuation Update With 7 Day Price Move • Sep 23
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₹64.85, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 18x in the Packaging industry in India. Total returns to shareholders of 81% over the past three years. New Risk • Sep 12
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹853.9m (US$9.67m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (8.3% average weekly change). Market cap is less than US$10m (₹853.9m market cap, or US$9.67m). Annuncio • Aug 12
Raaj Medisafe India Limited, Annual General Meeting, Sep 25, 2025 Raaj Medisafe India Limited, Annual General Meeting, Sep 25, 2025, at 15:00 Indian Standard Time. Reported Earnings • Aug 12
First quarter 2026 earnings released: EPS: ₹1.11 (vs ₹0.74 in 1Q 2025) First quarter 2026 results: EPS: ₹1.11 (up from ₹0.74 in 1Q 2025). Revenue: ₹158.3m (up 45% from 1Q 2025). Net income: ₹14.6m (up 50% from 1Q 2025). Profit margin: 9.2% (up from 8.9% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth. Annuncio • Aug 07
Raaj Medisafe India Limited to Report Q1, 2026 Results on Aug 11, 2025 Raaj Medisafe India Limited announced that they will report Q1, 2026 results on Aug 11, 2025 New Risk • Jul 03
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (8.9% average weekly change). High level of non-cash earnings (43% accrual ratio). Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (₹1.17b market cap, or US$13.7m). Valuation Update With 7 Day Price Move • Jun 25
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹89.70, the stock trades at a trailing P/E ratio of 19.3x. Average trailing P/E is 24x in the Packaging industry in India. Total returns to shareholders of 214% over the past three years. Reported Earnings • May 30
Full year 2025 earnings released: EPS: ₹4.60 (vs ₹3.05 in FY 2024) Full year 2025 results: EPS: ₹4.60 (up from ₹3.05 in FY 2024). Revenue: ₹626.2m (up 45% from FY 2024). Net income: ₹61.3m (up 84% from FY 2024). Profit margin: 9.8% (up from 7.7% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth. Annuncio • May 20
Raaj Medisafe India Limited to Report Q4, 2025 Results on May 27, 2025 Raaj Medisafe India Limited announced that they will report Q4, 2025 results on May 27, 2025 Valuation Update With 7 Day Price Move • May 08
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹75.60, the stock trades at a trailing P/E ratio of 29.7x. Average trailing P/E is 20x in the Packaging industry in India. Total returns to shareholders of 99% over the past three years. Valuation Update With 7 Day Price Move • Feb 27
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹77.09, the stock trades at a trailing P/E ratio of 30.3x. Average trailing P/E is 21x in the Packaging industry in India. Total returns to shareholders of 152% over the past three years. Reported Earnings • Feb 12
Third quarter 2025 earnings released: EPS: ₹0.76 (vs ₹0.86 in 3Q 2024) Third quarter 2025 results: EPS: ₹0.76. Revenue: ₹145.8m (up 43% from 3Q 2024). Net income: ₹10.3m (up 9.1% from 3Q 2024). Profit margin: 7.0% (down from 9.2% in 3Q 2024). The decrease in margin was driven by higher expenses. Annuncio • Feb 03
Raaj Medisafe India Limited to Report Q3, 2025 Results on Feb 11, 2025 Raaj Medisafe India Limited announced that they will report Q3, 2025 results on Feb 11, 2025 New Risk • Jan 27
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹850.0m (US$9.85m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.4% operating cash flow to total debt). High level of non-cash earnings (56% accrual ratio). Market cap is less than US$10m (₹850.0m market cap, or US$9.85m). Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). New Risk • Nov 26
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.4% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (9.1% average weekly change). High level of non-cash earnings (56% accrual ratio). Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (₹1.19b market cap, or US$14.1m). New Risk • Nov 16
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.4% operating cash flow to total debt). High level of non-cash earnings (56% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (₹1.19b market cap, or US$14.1m). Reported Earnings • Nov 13
Second quarter 2025 earnings released: EPS: ₹0.49 (vs ₹0.97 in 2Q 2024) Second quarter 2025 results: EPS: ₹0.49 (down from ₹0.97 in 2Q 2024). Revenue: ₹126.2m (up 13% from 2Q 2024). Net income: ₹6.52m (down 38% from 2Q 2024). Profit margin: 5.2% (down from 9.4% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings. Annuncio • Nov 06
Raaj Medisafe India Limited to Report Q2, 2025 Results on Nov 12, 2024 Raaj Medisafe India Limited announced that they will report Q2, 2025 results on Nov 12, 2024 Reported Earnings • Aug 15
First quarter 2025 earnings released: EPS: ₹0.74 (vs ₹0.58 in 1Q 2024) First quarter 2025 results: EPS: ₹0.74 (up from ₹0.58 in 1Q 2024). Revenue: ₹109.1m (up 3.7% from 1Q 2024). Net income: ₹9.74m (up 54% from 1Q 2024). Profit margin: 8.9% (up from 6.0% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 55% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹82.18, the stock trades at a trailing P/E ratio of 27x. Average trailing P/E is 23x in the Packaging industry in India. Total returns to shareholders of 441% over the past three years. Annuncio • May 25
Raaj Medisafe India Limited to Report Q4, 2024 Results on May 29, 2024 Raaj Medisafe India Limited announced that they will report Q4, 2024 results on May 29, 2024 Annuncio • May 24
Raaj Medisafe India Limited to Report Q4, 2024 Results on Sep 29, 2024 Raaj Medisafe India Limited announced that they will report Q4, 2024 results at 3:30 PM, Indian Standard Time on Sep 29, 2024 Valuation Update With 7 Day Price Move • May 07
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹58.72, the stock trades at a trailing P/E ratio of 20.1x. Average trailing P/E is 23x in the Packaging industry in India. Total returns to shareholders of 286% over the past three years. Valuation Update With 7 Day Price Move • Mar 14
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₹50.23, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 20x in the Packaging industry in India. Total returns to shareholders of 320% over the past three years. New Risk • Mar 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (1.1% operating cash flow to total debt). Market cap is less than US$10m (₹616.2m market cap, or US$7.44m). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change). Valuation Update With 7 Day Price Move • Feb 29
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹56.51, the stock trades at a trailing P/E ratio of 19.3x. Average trailing P/E is 22x in the Packaging industry in India. Total returns to shareholders of 425% over the past three years. Reported Earnings • Feb 11
Third quarter 2024 earnings released: EPS: ₹0.86 (vs ₹1.00 in 3Q 2023) Third quarter 2024 results: EPS: ₹0.86 (down from ₹1.00 in 3Q 2023). Revenue: ₹101.8m (up 6.5% from 3Q 2023). Net income: ₹9.40m (down 14% from 3Q 2023). Profit margin: 9.2% (down from 11% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 73% per year, which means it is well ahead of earnings. Annuncio • Feb 01
Raaj Medisafe India Limited to Report Q3, 2024 Results on Feb 09, 2024 Raaj Medisafe India Limited announced that they will report Q3, 2024 results on Feb 09, 2024 Valuation Update With 7 Day Price Move • Jan 10
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹44.92, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 23x in the Packaging industry in India. Total returns to shareholders of 383% over the past three years. Annuncio • Oct 31
Raaj Medisafe India Limited to Report Q3, 2023 Results on Nov 08, 2023 Raaj Medisafe India Limited announced that they will report Q3, 2023 results on Nov 08, 2023 New Risk • Oct 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (1.1% operating cash flow to total debt). Market cap is less than US$10m (₹459.5m market cap, or US$5.52m). Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Revenue is less than US$5m (₹390m revenue, or US$4.7m). New Risk • Sep 12
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 1.1% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (1.1% operating cash flow to total debt). Market cap is less than US$10m (₹427.8m market cap, or US$5.16m). Minor Risk Revenue is less than US$5m (₹390m revenue, or US$4.7m). Annuncio • Aug 09
Raaj Medisafe India Limited, Annual General Meeting, Sep 27, 2023 Raaj Medisafe India Limited, Annual General Meeting, Sep 27, 2023, at 15:00 Indian Standard Time. Reported Earnings • Aug 09
First quarter 2024 earnings released: EPS: ₹0.58 (vs ₹0.56 in 1Q 2023) First quarter 2024 results: EPS: ₹0.58 (up from ₹0.56 in 1Q 2023). Revenue: ₹105.2m (up 3.3% from 1Q 2023). Net income: ₹6.34m (up 3.5% from 1Q 2023). Profit margin: 6.0% (in line with 1Q 2023). Annuncio • Jul 30
Raaj Medisafe India Limited to Report Q1, 2024 Results on Aug 08, 2023 Raaj Medisafe India Limited announced that they will report Q1, 2024 results on Aug 08, 2023 Reported Earnings • Jun 03
Full year 2023 earnings released: EPS: ₹3.06 (vs ₹2.82 in FY 2022) Full year 2023 results: EPS: ₹3.06 (up from ₹2.82 in FY 2022). Revenue: ₹386.5m (up 11% from FY 2022). Net income: ₹33.3m (up 11% from FY 2022). Profit margin: 8.6% (down from 8.7% in FY 2022). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • May 29
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₹44.21, the stock trades at a trailing P/E ratio of 22.3x. Average trailing P/E is 18x in the Packaging industry in India. Total returns to shareholders of 25% over the past year. Annuncio • May 21
Raaj Medisafe India Limited to Report Q4, 2023 Results on May 29, 2023 Raaj Medisafe India Limited announced that they will report Q4, 2023 results on May 29, 2023 Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹28.33, the stock trades at a trailing P/E ratio of 14.3x. Average trailing P/E is 16x in the Packaging industry in India. Total loss to shareholders of 33% over the past year. Reported Earnings • Feb 15
Third quarter 2023 earnings released: EPS: ₹1.00 (vs ₹1.03 in 3Q 2022) Third quarter 2023 results: EPS: ₹1.00 (down from ₹1.03 in 3Q 2022). Revenue: ₹95.6m (up 6.3% from 3Q 2022). Net income: ₹10.9m (down 3.2% from 3Q 2022). Profit margin: 11% (down from 13% in 3Q 2022). The decrease in margin was driven by higher expenses. Annuncio • Feb 01
Raaj Medisafe India Limited to Report Q3, 2023 Results on Feb 08, 2023 Raaj Medisafe India Limited announced that they will report Q3, 2023 results on Feb 08, 2023 Valuation Update With 7 Day Price Move • Dec 22
Investor sentiment improved over the past week After last week's 18% share price gain to ₹35.95, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 15x in the Packaging industry in India. Total returns to shareholders of 272% over the past three years. Annuncio • Oct 30
Raaj Medisafe India Limited to Report Q2, 2023 Results on Nov 11, 2022 Raaj Medisafe India Limited announced that they will report Q2, 2023 results on Nov 11, 2022 Buying Opportunity • Sep 21
Now 20% undervalued Over the last 90 days, the stock is up 33%. The fair value is estimated to be ₹50.12, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last year. Earnings per share has grown by 4.5%. Annuncio • Sep 04
Raaj Medisafe India Limited, Annual General Meeting, Sep 28, 2022 Raaj Medisafe India Limited, Annual General Meeting, Sep 28, 2022, at 15:00 Indian Standard Time. Agenda: To receive, consider and adopt the audited financial statements of the company for the financial year ended March 31 2022 including audited balance sheet as at 31st March, 2022, statement of profit & loss account and cash flow statement for the year ended on that date and the reports of the board of directors and auditors thereon; to appoint a director in place of Smt. Krishna Jajoo who retires by rotation and being eligible offers herself for re-appointment. Valuation Update With 7 Day Price Move • Aug 25
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₹24.10, the stock trades at a trailing P/E ratio of 10.5x. Average trailing P/E is 13x in the Packaging industry in India. Total returns to shareholders of 125% over the past three years. Board Change • Aug 10
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Vijendra Sood was the last independent director to join the board, commencing their role in 2011. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annuncio • Aug 03
Raaj Medisafe India Limited to Report Q1, 2023 Results on Aug 09, 2022 Raaj Medisafe India Limited announced that they will report Q1, 2023 results on Aug 09, 2022 Board Change • Jul 18
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Vijendra Sood was the last independent director to join the board, commencing their role in 2011. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • May 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Vijendra Sood was the last independent director to join the board, commencing their role in 2011. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annuncio • May 26
Raaj Medisafe India Limited Announces Demise of Narendra Bahadur Singh, Independent Non-Executive Director Raaj Medisafe India Limited informed about the sad demise of Mr. Narendra Bahadur Singh, Independent Non-executive Director of the Company. Annuncio • May 19
Raaj Medisafe India Limited to Report Q4, 2022 Results on May 25, 2022 Raaj Medisafe India Limited announced that they will report Q4, 2022 results on May 25, 2022 Annuncio • Feb 07
Raaj Medisafe India Limited to Report Q3, 2022 Results on Feb 14, 2022 Raaj Medisafe India Limited announced that they will report Q3, 2022 results on Feb 14, 2022 Annuncio • Feb 03
Raaj Medisafe India Limited to Report Q3, 2021 Results on Feb 11, 2021 Raaj Medisafe India Limited announced that they will report Q3, 2021 results on Feb 11, 2021 
